Methamphetamine. Where applicable the above testing methods must be used for the purpose of section 12.1 of this policy. 50.34 Must be NATA Accredited.
Methamphetamine. Where applicable the above testing methods must be used for the purpose of section 12.1 of this policy.
Methamphetamine. To the best of Seller’s knowledge, methamphetamine production has not occurred on the Real Property.
Methamphetamine. For the purposes of satisfying any applicable requirements of Minn. Stat. § 152.0275, Subdiv. 2(m), to Seller’s knowledge, no methamphetamine production has occurred on the Property.
Methamphetamine. The equipment used to perform the test shall be used, tested and calibrated to the manufacturer's instructions and certified to AS 4760 (Processes for specimen collection and the detection and quantitation of drug in oral fluid). The drug testing shall be conducted by an accredited person, following all of the chain of custody provisions. The test must be performed in accordance with AS 4760 (Procedures for specimen collection and the detection and quantitation of drugs in oral fluid). This includes, but is not limited to: performing all the quality assurance requirements, such as negative and positive controls every 25 tests; the testing body must be accredited and independently audited by an organisation such as ISO or NATA; Collectors must be trained and receive a certificate of attainment in accordance with the Australian Quality Training Framework; Oral Fluid devices must have the recommended cut-off levels; Oral Fluid devices must undergo regular quality control checks including a positive and negative control every 25 tests, and one in 20 negative donor samples must be sent to an appropriately accredited laboratory to confirm a negative result; Collectors are required to explain the procedures to each donor, conduct an approved identity check, and have them complete a consent form; Collection and performance of the initial test must be performed in the presence of the donor; and An unconfirmed (non-negative) sample must be despatched under strict chain of custody procedures including a second reference sample which has been collected at the same time. The quantification analysis of the samples detected as non-negative in the on-site device must be conducted in a NATA accredited laboratory for confirmation testing. The above does not apply to self-testing to the extent that it is inconsistent with the self-testing regime.
Methamphetamine. If the Property is residential, and Seller knows that methamphetamine was ever manufactured, processed, cooked, disposed of, used or stored at the Property, Seller is required to disclose such fact. No disclosure is required by law if the Property was remediated in accordance with state standards and other requirements are fulfilled pursuant to C.R.S. § 25-18.5-102; provided however, that Seller nonetheless hereby agrees to provide such disclosure to the extent of Seller’s actual knowledge thereof. Purchaser further acknowledges that Purchaser has the right to engage a certified hygienist or industrial hygienist to test whether the Property has ever been used as a methamphetamine laboratory. If Purchaser's test results indicate that the Property has been contaminated with methamphetamine, but has not been remediated to meet the standards established by the rules of the State Board of Health promulgated pursuant to C.R.S. § 25-18.5-102, Purchaser shall promptly give written notice to Seller of the results of the test, and Purchaser may terminate this Agreement, notwithstanding any other provision of this Agreement.
Methamphetamine. Seller is not aware of any methamphetamine production that has occurred on the Property.
Methamphetamine. Short-term abstinent methamphetamine abusers (those who have been abstinent for 4 – 14 days) exhibit decrements in memory and learning, psychomotor speed, and informational processing (Xxxxx and Xxxxxx, 2011;Xxxxxxxx, Xxxxx, Xxx-Xxx, and Xxxxx, 2005). Chronic methamphetamine users also demonstrate lower performance on immediate and delayed verbal memory tasks (Xxxxx and Xxxxxx, 2011; Xxxxxxx et al., 2006; Xxxxxxxxx, Xxxxx, Xxxxx, et al., 2010; Xxxxxx, Xxxxxx, Xxxxx et al., 2010), with decrements in immediate visual recall and delayed memory (Xxxxx and Xxxxxx, 2011; Xxxxxxxxx et al., 2010; Xxxxxx et al., 2010; Xxxxx, Xxxxxxx, Xxxxxxx, et al., 2005). Chronic amphetamine and opiate abuse is marked by deficits on a range of neuropsychological tasks involving attentional control, planning, and spatial working memory (Xxxxxx and Xxxxxxx, 2001; Xxxxxxxx et al., 2000). It should be noted, however, that there are subtle differences in the profile of deficits shown between amphetamine abusers and opiate abusers. One such differences is that amphetamine abusers are marked more by impairments in the control of attentional bias but have milder deficits in the use of strategy in spatial memory tasks. Furthermore, abstinent amphetamine users (those who have been abstinent for more than one year, with the mean duration of abstinence being 8 years) display diminished cognitive planning and poorer immediate/delayed pattern recognition compared to controls (Xxxxx and Xxxxxx, 2011; Xxxxxxxxxx, Erb, and Xxxxxxxx, 2005). However, the normalization of executive functioning in methamphetamine users who have been abstinent for more than one year has also been shown (Xxxxx and Schilt, 2011; Xxxx et al., 2009). Ecstasy (MDMA) users exhibit impairments in tests of short-term memory and more complex attentional functioning (Xxxxxx and Xxxxxxx, 2001; Xxxxxxx et al., 1992; Xxxxx et al., 1999; XxXxxx, Xxxxx, Xxxxxxxxxxxxx, and Xxxxxxxx, 1999; Xxxxxxxxx-Mayfrank et al., 2000). There is evidence, however, that MDMA use results in impairments in verbal learning and memory ability and improvements in design fluency (Xxxxxx, Shear, and Xxxxxxxx, 2005). Furthermore, this study reports no significant relationship between MDMA consumption and executive functioning or attentional abilities. Recent research indicates the possibility that certain impairments may require additional methods of assessment. Electroencephalography findings suggest evidence of abnormal executive functioning in ecstasy po...
Methamphetamine. The Town has no knowledge that methamphetamine was ever manufactured, processed, cooked, disposed of, used or stored at the Property. Buyer acknowledges that Buyer has the right to engage a certified hygienist or industrial hygienist to test whether the Property has ever been used as a methamphetamine laboratory, and Buyer has the right to terminate this Agreement on or before the Inspection Objection Deadline and recover the Deposit, based on test results that indicate the Property has been contaminated with methamphetamine, but has not been remediated to meet the standards established by rules of the State Board of Health promulgated pursuant to C.R.S. § 25-18.5-102. Buyer shall promptly give the Town notice of the results of such a test.
Methamphetamine. To Seller’s knowledge, no methamphetamine production has occurred on the Minnesota Property.
